LOX and infantile convulsions and choreoathetosis: Notably, FOX plus PXS-5505 improved overall survival compared to FOX alone, demonstrating the effectiveness of combination therapy with pan-LOX inhibition for treating autochthonous iCCA tumors (Figure 7E).